Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/20/2025

L-Carnitine Supplementation Guidelines

Introduction to L-Carnitine

  • The general population should not routinely use L-carnitine supplementation for measurable health benefits, as there is insufficient evidence to support its use [1]

Clinical Scenarios for L-Carnitine Use

  • L-carnitine may help reduce erythropoietin requirements in dialysis patients with anemia who are unresponsive to standard therapies [2]
  • Short-term trials (3-4 months) of L-carnitine may be reasonable for selected dialysis patients with muscle weakness, exercise intolerance, post-dialysis asthenia (fatigue), or intradialytic muscle cramps [2]
  • Limited evidence suggests that L-carnitine may improve ejection fraction in some hemodialysis patients [2]
  • L-carnitine is essential for the treatment of primary carnitine deficiency, a genetic disorder of the cellular carnitine-transporter system [1]

Prevention of Deficiency

  • L-carnitine may be considered for prevention of deficiency in patients on prolonged parenteral nutrition at doses of 0.5-1g/day [1]

Dosage and Administration

  • Standard dosing of 0.5-2g/day has a favorable safety profile [4]
  • Higher doses (≥3g/day) may cause side effects, including nausea, vomiting, abdominal cramps, diarrhea, "fishy" body odor, muscle weakness in uremic patients, and seizures in those with seizure disorders [1]

Monitoring and Contraindications

  • Patients on thyroid medication should have their thyroid function tests monitored 6-8 weeks after starting L-carnitine [4]
  • Dialysis patients should be monitored for response to therapy over 3-4 months to determine benefit [2]
  • L-carnitine should be avoided in healthy individuals, for lipid management, and as a general supplement for exercise performance [1, 2]

Methodological Limitations

  • Many studies on L-carnitine have methodological limitations, including small sample sizes, heterogeneous protocols, and variable assessment methods [2]
  • Publication bias may have influenced the available literature, with negative studies less likely to be published [2]
  • L-carnitine should be taken at different times than levothyroxine to avoid potential interference with absorption [4]

REFERENCES

1

espen micronutrient guideline. [LINK]

Clinical Nutrition, 2022

3

L-Carnitine Supplementation and Thyroid Medication [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025